Related Experiment Video
Updated: Jan 26, 2026

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
Newborn screening for cystic fibrosis: Is there benefit for everyone?
1Department of Paediatric Respiratory Medicine and Cystic Fibrosis, Children's Hospital for Wales, Cardiff, United Kingdom.
Insights
Newborn screening for cystic fibrosis (CF) identifies infants with inconclusive diagnoses (CF-SPID). Management strategies are needed for these children, considering potential psychosocial impacts despite mild or no symptoms.
Area of Science:
- Genetics
- Public Health
- Pediatrics
Background:
- Newborn screening for cystic fibrosis (CF) is a global public health strategy.
- Optimal screening methods and gene panels lack consensus.
- Advancements in CFTR genetics create diagnostic uncertainty.
Purpose of the Study:
- To address the emergence of Cystic Fibrosis Screen Positive Inconclusive Diagnosis (CF-SPID).
- To question the role and management of newborn screening for CF.
- To explore the psychosocial impact on children with CF-SPID.
Main Methods:
- Review of current newborn screening protocols for CF.
- Analysis of CFTR genetics and phenotypic variability.
- Discussion of diagnostic uncertainty and management pathways.
Main Results:
- Newborn screening identifies a subset of infants with CF-SPID.
- These infants may be clinically well or have mild phenotypes.
- Psychosocial impacts can occur despite a lack of severe symptoms.
Conclusions:
- Current newborn screening for CF requires re-evaluation.
- Optimal management strategies for CF-SPID are needed.
- Balancing screening benefits with potential harms is crucial.
Abstract:
Newborn screening for cystic fibrosis (CF) has become a widely accepted and endorsed public health strategy in economically developed countries, although there is little consensus on optimal screening methods and gene panels. Increasing understanding of CFTR genetics and consequent unpredictability of phenotypic and clinical outcomes lead to diagnostic uncertainty, and emergence of Cystic Fibrosis Screen Positive Inconclusive Diagnosis (CF-SPID). Many of these children are clinically well or have a mild phenotype yet may still experience the psychosocial impact of a CF diagnosis. This questions the role of newborn screening and how best to manage those it identifies with CF-SPID.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Benefits of Self-Esteem
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Imprinting
Symbiosis

